Specialty Pharma Journal Specialty, Precision & Technology
No job listings found.
Breaking News
- Fulcrum Acquires Global Rights to Losmapimod, a Potential Therapy for Facioscapulohumeral Muscular Dystrophy
- FSD Pharma to Acquire Prismic Pharmaceuticals for $17.5 Million
- FDA Approves Merck’s Keytruda in Combination with Inlyta as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
- Lilly Announces Positive Top-Line Results from its Phase 3 Study Evaluating Taltz in Non-Radiographic Axial Spondyloarthritis
- Lilly and Avidity Biosciences Enter License and Research Collaboration in Immunology and Other Indications
- FDA Permits Marketing of First Medical Device for Treatment of Attention Deficit Hyperactivity Disorder
- Pfizer and Lilly Announce Top-Line Results from its Long-Term Phase 3 Study of Tanezumab in Osteoarthritis Patients
- Inovio Publishes Cancer Killing Data of Its Transformative DNA-encoded Bi-specific T Cell Engagers in a Peer-reviewed Journal
- Viela Bio’s Inebilizumab Receives Breakthrough Therapy Designation from the FDA for Treatment of Neuromyelitis Optica Spectrum Disorder
- Mallinckrodt Reports Top-Line Results from Proof-of-Concept Study of Nitric Oxide Gas in Ex-Vivo System of Human Lung Transplants